| |
| |
|
| Insider
Information: |
Kayyem Jon Faiz |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
375,074 |
|
|
Indirect Shares
|
13,968,279 |
|
|
| Direct
Value |
$4,750,833 |
|
|
|
Indirect Value
|
$17,161,998 |
|
|
| Total
Shares |
14,343,353 |
|
|
| Total
Value |
$21,912,830 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aeolus Pharmaceuticals Inc |
AOLS |
10% Owner |
|
0 |
2006-06-05 |
9,800,000 |
Premium* |
|
|
Genmark Diagnostics, Inc. |
GNMK |
SVP, Research & Develo... |
2018-02-02 |
197,622 |
2018-02-02 |
713,893 |
Premium* |
|
|
Inhibrx, Inc. |
INBX |
Director |
2022-08-02 |
0 |
2023-01-23 |
3,274,301 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2023-08-03 |
177,452 |
2023-08-03 |
180,085 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BDSX |
Biodesix Inc |
|
• • – |
2023-08-03 |
4 |
A |
$1.62 |
$9,999 |
I/I |
6,172 |
180,085 |
0 |
- |
|
| INBX |
Inhibrx, Inc. |
Director |
– • – |
2023-01-23 |
4 |
AS |
$25.26 |
$239,999 |
I/I |
(9,500) |
3,224,301 |
0 |
- |
|
| INBX |
Inhibrx, Inc. |
Director |
– • – |
2022-12-21 |
4 |
AS |
$26.87 |
$256,679 |
I/I |
(9,500) |
3,233,801 |
0 |
- |
|
| BDSX |
Biodesix Inc |
|
• • – |
2022-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,619 |
31,619 |
0 |
- |
|
| BDSX |
Biodesix Inc |
|
• • – |
2022-11-21 |
4 |
B |
$1.15 |
$200,000 |
I/I |
173,913 |
173,913 |
0.01 |
- |
|
| INBX |
Inhibrx, Inc. |
Director |
– • – |
2022-11-21 |
4 |
AS |
$29.33 |
$283,972 |
I/I |
(9,500) |
3,243,301 |
0 |
- |
|
| INBX |
Inhibrx, Inc. |
Director |
– • – |
2022-10-21 |
4 |
AS |
$29.39 |
$286,232 |
I/I |
(9,500) |
3,252,801 |
0 |
- |
|
| INBX |
Inhibrx, Inc. |
Director |
– • – |
2022-08-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
11,900 |
3,262,301 |
0 |
- |
|
| INBX |
Inhibrx, Inc. |
Director |
– • – |
2022-08-05 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,400 |
3,274,201 |
0 |
- |
|
| INBX |
Inhibrx, Inc. |
Director |
– • – |
2022-08-02 |
4 |
GD |
$0.00 |
$0 |
I/I |
118,500 |
3,277,601 |
0 |
- |
|
| INBX |
Inhibrx, Inc. |
Director |
– • – |
2022-08-02 |
4 |
GA |
$0.00 |
$0 |
I/I |
50,000 |
25,000 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
• – – |
2018-02-02 |
4 |
S |
$5.13 |
$759 |
D/D |
(148) |
197,622 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
• – – |
2017-12-04 |
4 |
S |
$4.70 |
$635 |
D/D |
(135) |
197,770 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
• – – |
2017-11-20 |
4 |
S |
$4.74 |
$6,015 |
D/D |
(1,269) |
197,905 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
• – – |
2017-11-02 |
4 |
S |
$7.24 |
$977 |
D/D |
(135) |
199,174 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
• – – |
2017-09-05 |
4 |
S |
$9.75 |
$1,297 |
D/D |
(133) |
199,309 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
• – – |
2017-08-21 |
4 |
S |
$9.45 |
$12,068 |
D/D |
(1,277) |
199,442 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
• – – |
2017-08-02 |
4 |
S |
$10.33 |
$1,426 |
D/D |
(138) |
200,719 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
• – – |
2017-06-02 |
4 |
S |
$12.89 |
$1,701 |
D/D |
(132) |
200,857 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
• – – |
2017-05-19 |
4 |
S |
$12.89 |
$16,306 |
D/D |
(1,265) |
200,989 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
• – – |
2017-05-02 |
4 |
S |
$13.34 |
$1,774 |
D/D |
(133) |
202,254 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
• – – |
2017-03-07 |
4 |
S |
$12.18 |
$3,788 |
D/D |
(311) |
202,387 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
• – – |
2017-03-03 |
4 |
S |
$12.29 |
$1,610 |
D/D |
(131) |
202,698 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
• – – |
2017-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
48,750 |
202,829 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
• – – |
2017-02-21 |
4 |
S |
$10.08 |
$52,920 |
D/D |
(5,250) |
154,079 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
